Rep. Mariannette Miller-Meeks

Maddy summaryThis bill (HCONRES 67) authorizes the use of the U.S. Capitol rotunda for the ceremonial "lying in state" of two Iowa National Guard soldiers: Sergeant Edgar Brian Torres-Tovar and Sergeant William Nathaniel Howard. It specifically permits their remains to be displayed in the rotunda, as determined by Capitol officials, following their service in the 1st Squadron of the 113th Cavalry Regiment. The resolution is purely procedural, recognizing their military service without creating new laws or affecting policy. It directly involves Capitol staff who would arrange the ceremony and the families of the deceased soldiers.

Miracle on Ice Congressional Gold Medal Act This act provides for the award of Congressional Gold Medals to the members of the 1980 U.S. Olympic men's ice hockey team in recognition of the team's achievement at the 1980 Winter Olympic Games.

Maddy summaryThis bill bans online platforms from conducting market research on children under 13 and requires parental permission for such research on teens aged 13-17. It applies to social media and apps that let users create profiles, share content, and use features like auto-play or notifications to keep users engaged. Platforms must stop collecting data about minors' behavior without consent, with enforcement led by the Federal Trade Commission. States can also sue platforms that violate these rules.

Maddy summaryHR 5360, the AWARE Act, requires the Federal Trade Commission (FTC) to create and publish public educational resources about AI chatbot safety within 180 days of the bill becoming law. These resources will specifically help parents, educators, and minors (under age 18) understand safe AI chatbot use, including how to identify risks, privacy practices, and supervision strategies. The FTC must model these materials after its existing Youville program. The bill defines "AI chatbot" as consumer-facing interactive AI systems but does not regulate or restrict chatbot development or use.

Maddy summarySammy's Law requires large social media platforms (those with over 100 million monthly users or $1 billion in annual revenue) to create real-time tools allowing parents or third-party safety software providers to help protect children under 17 from online harms. Platforms must provide secure access to children's account data for safety software providers that register with the Federal Trade Commission and meet strict security and privacy requirements. Third-party providers can only use the data to address specific risks like cyberbullying, trafficking, or abuse, and must delete data after 14 days unless needed for a safety concern. The law creates a federal standard that prevents states from making their own rules about this type of platform access.

Maddy summaryHRES 932 is a symbolic resolution passed by the House of Representatives that condemns six specific members of Congress (including Senators Kelly and Slotkin and Representatives Crow, Deluzio, Goodlander, and Houlahan) for allegedly making statements that encouraged military and intelligence personnel to disobey orders from the President. The resolution claims these lawmakers falsely suggested the administration issued "illegal orders" and undermined the military chain of command, violating the Uniform Code of Military Justice (UCMJ). It does not create new laws or policies but formally denounces the lawmakers' statements as "dangerous and seditious rhetoric." As a procedural resolution, it has no binding effect on military conduct or policy.

Maddy summaryHR 6423, the HELP Copays Act, requires health insurance plans and coverage to count financial assistance from non-profits or drug manufacturers toward patient cost-sharing limits like deductibles and copayments. This directly affects patients enrolled in health insurance who receive such assistance for prescription drugs, ensuring the help they get reduces their out-of-pocket costs faster. The bill amends key health laws to mandate that these payments are included when calculating whether a patient has met their deductible or copayment threshold. The change applies to all prescription drugs, including specialty drugs and those subject to prior authorization, but does not alter how insurers manage drug access through tools like step therapy. It takes effect for plan years starting in 2026.

Maddy summaryThe PRECISE Act amends existing agricultural programs to specifically support farmers adopting precision agriculture practices and technology. It expands eligibility under the Conservation Loan Program (Section 304 of the Farm and Rural Development Act) for loans covering precision agriculture tools like GPS guidance, soil sensors, and data software. Farmers using these loans can also receive increased payments through the Environmental Quality Incentives Program (EQIP), with costs for precision agriculture practices covered up to 90% of expenses. The bill directly affects agricultural producers seeking to improve efficiency, reduce input waste, and enhance environmental outcomes through technology adoption.

Maddy summaryThis bill suspends payment limits for agricultural subsidies for the 2025 crop year, removing caps on payments to farmers. It also establishes a new option for farmers to receive 50% of their expected 2025 crop payments as an advance by December 1, 2025, if they opt in. The remaining balance is paid later after the marketing year ends, with farmers required to repay any overpayment if the final amount exceeds the advance. The bill directly affects farmers growing covered commodities (like corn, soybeans) who choose to participate in the advance payment program.

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)